ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1300

$573K Total Retail Price of All Prescriptions

Rank: 21 out of 1300

348 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 7,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
WARFARIN SODIUM 793 708 1 9
LISINOPRIL 395 321 2 2
LEVOTHYROXINE SODIUM 333 273 3 1
FUROSEMIDE 330 261 4 8
GABAPENTIN 250 174 5 15
SIMVASTATIN 243 175 6 3
HYDROCODONE-ACETAMINOPHEN 232 187 S3 7 5
METOPROLOL TARTRATE 205 178 8 11
NAMENDA 182 170 9 51
LANTUS 159 89 10 43
DIVALPROEX SODIUM 146 127 11 62
DONEPEZIL HCL 145 141 12 32
OMEPRAZOLE 143 117 13 4
TRAMADOL HCL 142 109 14 17
OXYCODONE HCL 124 97 S2 15 35
MIRTAZAPINE 124 105 15 50
AMLODIPINE BESYLATE 118 103 17 6
TAMSULOSIN HCL 114 73 18 25
BACLOFEN 107 38 19 100
LEVETIRACETAM 103 54 20 107
POLYETHYLENE GLYCOL 3350 103 47 20 65
VENLAFAXINE HCL ER 102 72 22 69
SERTRALINE HCL 100 59 23 26
PAROXETINE HCL 99 47 24 59
METFORMIN HCL 97 55 25 7
RISPERIDONE 94 37 26 77
CYMBALTA 93 51 27 44
LEVOFLOXACIN 92 57 28 103
CITALOPRAM HBR 91 74 29 19
ALENDRONATE SODIUM 88 60 30 20
KLOR-CON M20 88 68 30 60
POTASSIUM CHLORIDE 82 81 32 18
CEPHALEXIN 81 46 33 89
ESCITALOPRAM OXALATE 79 72 34 84
TRAZODONE HCL 73 36 35 34
HYDROCHLOROTHIAZIDE 72 40 36 10
NYSTOP 69 54 37 188
FINASTERIDE 66 56 38 80
CIPROFLOXACIN HCL 63 35 39 87
TIZANIDINE HCL 63 0 39 163
CARBIDOPA-LEVODOPA 61 30 41 68
OXYCODONE-ACETAMINOPHEN 60 33 S2 42 28
LIDODERM 59 55 43 74
HYDRALAZINE HCL 58 56 44 133
CRESTOR 58 58 44 39
RANITIDINE HCL 55 32 46 27
ATENOLOL 54 53 47 12
OXYBUTYNIN CHLORIDE 54 29 47 97
NOVOLOG 54 49 47 156
QUETIAPINE FUMARATE 53 44 50 57
GLIPIZIDE 53 53 50 33
NOVOLIN R 52 28 52 211
SEROQUEL 50 42 53 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.